Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDODS.L Regulatory News (DODS)

  • There is currently no data for DODS

Offer Update

19 Aug 2005 07:00

Huveaux PLC18 August 2005 Not for release, publication or distribution in or into the United States,Australia, Canada, Japan or any other jurisdiction if to do so would constitutea violation of the relevant laws of such jurisdiction For immediate release 19 August 2005 Epic Group plc ("Epic") Offer update The board of Huveaux announces that by 3.00 p.m. (U.K. time) on 18 August 2005,the first closing date of the Offer, valid acceptances of the Offer had beenreceived in respect of a total of 18,866,747 Epic Shares, representingapproximately 78.17 per cent. of the existing issued share capital of Epic as at3.00 p.m. (U.K. time) on 18 August 2005. This total includes acceptances in respect of 12,399,243 Epic Shares,representing approximately 51.37 per cent. of the existing issued share capitalof Epic as at 3.00 p.m. (U.K. time) on 18 August 2005, pursuant to theirrevocable undertakings and the letter of intent to accept the Offer from theDirectors of Epic and certain other Epic Shareholders. In accordance with the terms and conditions of the Offer, the Board of Huveauxannounces that all outstanding conditions of the Offer have either beensatisfied or waived save for the condition relating to the admission of up to32,563,191 New Huveaux Shares to AIM, a market operated by the London StockExchange, becoming effective ("Admission"). Accordingly, the Offer is declaredunconditional in all respects subject only to such Admission, which is expectedto become effective on 22 August 2005. The Offer will be open for acceptanceuntil further notice but the Mix and Match Facility is no longer available foracceptances. Huveaux intends to procure that Epic applies to the London Stock Exchange forthe trading of Epic Shares on AIM to be cancelled. It is anticipated that suchcancellation will take effect no earlier than 20 September 2005, being 20business days after the Offer is expected to be declared unconditional in allrespects. To the extent they have not already done so, Epic Shareholders who hold theirEpic Shares in certificated form and who wish to accept the Offer shouldcomplete, sign and return their Forms of Acceptance as soon as possible inaccordance with the instructions set out in the Offer Document and in the Formof Acceptance. Epic Shareholders who hold their Epic Shares in uncertificated form and who wishto accept the Offer should send to CRESTCo a TTE Instruction in relation to suchshares as soon as possible. The procedure for acceptance of the Offer is set outin paragraph 15 of Part II of the Offer Document. Save as disclosed in this announcement, neither Huveaux, nor any persons acting,or deemed to be acting, in concert with Huveaux held any Epic Shares (or rightsover Epic Shares) or has acquired or agreed to acquire any Epic Shares (orrights over Epic Shares) during the Offer Period. Words and expressions defined in the Offer Document dated 28 July 2005 shallhave the same meaning when used in this announcement. Copies of the documentsposted to Epic Shareholders on 28 July 2005 are available for inspection at theDocument Viewing Facility of the UK Listing Authority at The Financial ServicesAuthority, 25 The North Colonnade, London E14 5HS. Enquiries Huveaux 020 7245 0270 John van Kuffeler, Executive Chairman Dresdner Kleinwort Wasserstein (Financial advisor to Huveaux) 020 7623 8000Joe Thompson Finsbury (Public Relations advisor to Huveaux) 020 7251 3801James LevitonKatie LangDon Hunter Dresdner Kleinwort Wasserstein, which is authorised and regulated by theFinancial Services Authority, is acting for Huveaux and for no-one else inconnection with the Offer and will not be responsible to anyone other thanHuveaux for providing the protections afforded to customers of DresdnerKleinwort Wasserstein, or for providing advice in relation to the Offer or anymatters referred to herein. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
9th Jul 20187:00 amRNSDirectorate Change
27th Jun 20187:00 amRNSPosting of Annual Report and Notice of AGM
25th Jun 20187:00 amRNSLaunch of New Products
14th Jun 20187:00 amRNSLaunch of New Products
7th Jun 20187:00 amRNSFinal Results
6th Feb 20182:39 pmRNSIssue of Equity
6th Feb 201810:45 amRNSHolding(s) in Company
29th Nov 20177:00 amRNSDirectorate Changes
16th Nov 20177:01 amRNSHalf-year Report
16th Nov 20177:00 amRNSAcquisition
5th Jul 201710:38 amRNSResult of AGM
12th Jun 20177:00 amRNSNotice of AGM
25th May 20179:14 amRNSAnnual Financial Report
25th May 20177:00 amRNSFinal Results
4th Apr 20178:40 amRNSHolding(s) in Company
20th Feb 20174:08 pmRNSDirector/PDMR Shareholding
16th Feb 201712:45 pmRNSStrategic Investment
5th Jan 20177:00 amRNSNew Corporate Website
24th Nov 20167:00 amRNSDirector/PDMR Shareholding
24th Nov 20167:00 amRNSDirector/PDMR Shareholding
9th Nov 20167:00 amRNSHalf-year Report
19th Sep 201610:12 amRNSChange of Registered Office
5th Sep 20167:00 amRNSDirectorate Change
4th Aug 20164:42 pmRNSHolding(s) in Company
4th Aug 20167:00 amRNSDirectorate Change
28th Jul 20164:23 pmRNSResult of AGM
4th Jul 201612:00 pmRNSIssue of Equity
31st May 20162:05 pmRNSHolding(s) in Company
26th May 20164:24 pmRNSDirector/PDMR Shareholding
23rd May 20161:12 pmRNSAnnual Financial Report
23rd May 20169:55 amRNSFinal Results
31st Mar 20163:12 pmRNSDirector/PDMR Shareholding
31st Mar 201611:48 amRNSDirector/PDMR Shareholding
29th Mar 20165:31 pmRNSDirector/PDMR Shareholding
29th Mar 201610:40 amRNSIssue of Equity
24th Mar 20165:04 pmRNSDirectorate Change
18th Mar 20167:00 amRNSHolding(s) in Company
27th Oct 201510:13 amRNSHalf Yearly Report
30th Sep 201512:22 pmRNSDirector/PDMR Shareholding
3rd Aug 201511:33 amRNSResult of AGM
21st Jul 20159:38 amRNSHolding(s) in Company
26th Jun 201512:18 pmRNSDirector/PDMR Shareholding
24th Jun 20157:00 amRNSAnnual Financial Report
23rd Jun 20157:00 amRNSPreliminary Results
19th Feb 20156:16 pmRNSDirector/PDMR Shareholding
9th Feb 20155:39 pmRNSDirector/PDMR Shareholding
6th Jan 20152:25 pmRNSDirector/PDMR Shareholding
17th Dec 20144:41 pmRNSDirector/PDMR Shareholding
19th Nov 20143:37 pmRNSDirectorate Change
12th Nov 20147:00 amRNSHalf Yearly Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.